Chemoradiation followed by adjuvant durvalumab in stage III non–small cell lung cancer: Real‐world comparison of treatment outcomes to historical controls treated with chemoradiation alone

OBJECTIVE: Compare outcomes in patients with stage III non–small cell lung cancer (NSCLC) treated with chemoradiation and adjuvant durvalumab to historical controls treated with chemoradiation alone. METHODS: The records of patients with stage III NSCLC treated with definitive chemoradiation ± adjuv...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Akram, Goldstein, Jeffrey, Appel, Sarit, Daher, Sameh, Urban, Damien, Onn, Amir, Gantz‐Sorotsky, Hadas, Lobachov, Anastasiya, Gottfried, Teodor, Spieler, Benjamin, Bar, Jair
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200887/
https://www.ncbi.nlm.nih.gov/pubmed/35538909
http://dx.doi.org/10.1111/1759-7714.14452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9200887/
https://www.ncbi.nlm.nih.gov/pubmed/35538909
http://dx.doi.org/10.1111/1759-7714.14452

Ejemplares similares